1Chu A, Flynn MB, Achino E, et al. Irradiation of nasopharyngeal carcinoma: Correlations with treatment factors and stage. Int J Radiat Oncol Biol Phys, 1984,10:2241.
2Leung TW, Tung SY, Sze WK, et al. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2000,47:405.
3Le QT, Tate D, Koong A, et al. Improve local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys, 2003,56:1046.
4David J, Adler JR, Chang SD, et al. Stereotactic tadiosurgery boost following tadiotherapy in primary nasopharyngeal carcinoma: impact on local control. Int J Radiation Oncology Biol Phys, 1999,45:915.
5Pai PC, Chuang CC, Wei KC, et al. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head & Neck, 2002,21:748.
6Danid T, Jonathan S, Philip W, et al. Linear accelertor- based stereotactic radiosurgery for limited, locally persistent, and recrrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiation Oncology Biol Phys, 2003,56:177.
7Xiao JP, Xu GZ, Miao YJ. Fractionated stereotactic radiosurgery for 50 patients with recrrent or residual nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys, 2001,51:164.
8Ahn YC, Lee KC, Kim DY, et al. Fractionated stereotactic radiation therapy for extracranial head and neck tumors. Int J Radiat Oncol Biol Phys, 2000,48(2) :501.
9Nishioka T, Shirato H, Kagei K, et al. Three- dimensional small - volume irradiation for residual or recrrent nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys, 2000,48:495.
10Zheng XK, Chen LH, Chen YQ, et al. Three- dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma. Int J Radiation Oncology Biol Phys, 2004,60:165.
10Forastiere AA, Neuberg D, Taylor SG, et al. Phase I1 evaluation Of Taxol in advanced head and neck cancer: An Eastern Cooperative Oncology group trial . J Natl Cancer Inst Monogr, 1993, 15: 181-184.
